期刊文献+

239例卡马西平药疹的临床荟萃分析 被引量:5

Literature Analysis of 239 Patients with Drug Eruption Induced by Carbamazepine
下载PDF
导出
摘要 目的探讨国人因卡马西平所致药疹的临床特点及预后转归。方法通过中国医院知识数据库(CHKD),以"卡马西平and药疹and临床分析"为关键词,对1996年1月至2011年12月发表的中文文章进行检索,提取其中有关卡马西平药疹患者的临床资料并进行汇总分析。结果共11项临床分析中的239例患者进入本研究,其中男130例,女109例。平均发病年龄为39.13岁。男女比例接近。卡马西平药疹重症型的发生率达59.18%,皮损类型由高到低依次为:SJS、ED、TEN。潜伏期平均为11.91d,平均住院时间为28.70d。卡马西平重症药疹患者出现发热的比例为100%,血白细胞数目异常者占51.46%,有肝功能损害的占66.02%,肾功能损害的占31.07%。其他常见的还有高血糖、尿血及尿蛋白等异常。卡马西平药疹的治愈率为94.57%,无明确死亡病例报道。结论我国卡马西平药疹的发病以青壮年为主,临床表现可以多种多样,潜伏期长,发生重症的比例比普通药疹高,常伴多系统损害,在临床工作中应高度重视。 Objeetive To analyze the clinical features and prognosis of the carbamazepine-induced drug eruption. Methods The literatures published from 1996.1 to 2011.12 in CHKD with the keyword 'carbamazepine and drug eruption and clinical analysis' were reviewed and the clinical data of carbamazepine- induced drug eruption patients were analyzed. Results In 239 patients of 11 clinical studies, there were 130 males and 109 females. The mean onset age was 39.13 years old. Among them 59.18% were severe subtypes, in which the percentage of febricity, WBC anomaly, hepatic and renal dysfunction was 100%,51.46%, 66.02% and 31.07% respectively. The total cure rate was 94.57% and no case died. The latent period was 11.91 days and the average length of stay was 28.70days. Conclusion Carbamazepine-induced drug eruption has a higher incidence in the middle-age. Its clinical manifestations can be various and more likely to become severe subtypes that combined with systemic damages. It is necessary for clinicians to pay attention to this kind of drug eruption.
出处 《中国医药指南》 2013年第11期9-10,共2页 Guide of China Medicine
关键词 卡马西平 药疹 临床分析 汇总分析 Carbamazepine Drug eruption Clinical analysis Literature analysis
  • 相关文献

参考文献7

二级参考文献53

共引文献60

同被引文献29

  • 1李倩,惠艳.药疹的实验室诊断研究进展[J].中国全科医学,2009,12(8):707-710. 被引量:6
  • 2艾哈迈德,郑捷.药疹发病机理研究的几个热点[J].实用皮肤病学杂志,2009,2(3):149-152. 被引量:10
  • 3刘蓉,周东,陈芹.卡马西平引起重型药疹22例临床分析[J].四川医学,2006,27(7):711-713. 被引量:8
  • 4薛建健,王静,廖达林,倪铭孔,彭明.卡马西平致大疱性表皮松解症1例的护理[J].中国误诊学杂志,2007,7(12):2903-2903. 被引量:3
  • 5李瑞珍,宋伟峰,刘杰.卡马西平致不良反应文献分析.药事组织,2005,14(5):57-58.
  • 6Mockenhaupt M. The current understanding of Stevens--Johnson syndrome and toxic epidermal neerolysis [J ] . Expert R.ev Clin lmmunol, 2011, 7 (6) :803-813.
  • 7JARAMILLO N M,GALINDO I F,VAZQUEZ A 0, et al. Phar-macogenetic potential biomarkers for carbamazepine adverse drug re-actions and clinical response [ J ]. Drug Metabol Drug Interact,2014,29(2) :67 -79.
  • 8HE X J, JIAN L Y, HE X h, et al. Association of ABCB1,CYP3A4, EPHX1, FAS, SCN1A, MICA,and BAG6 polymor-phisms with the risk of carbamazepine - induced Stevens - Johnsonsyndrome/toxic epidermal necrolysis in Chinese Han patients "withepilepsy[ J]. Epilepsia, 2014,55(8) : 1301 - 1306.
  • 9PARK P W, SEO Y H, AHN J Y, et al. Effect of CYP3A5 * 3 geno-type on serum carbamazepine concentrations at steady - state in Koreanepileptic patients[ J]. J Clin PharmTher, 2009,34(5) :569.
  • 10王剑虹,吴洵映,朱国行,等.卡马西平所致皮肤不良反应与CYP3A5基因多态性相关性的研究[EB/OL].重庆:第五届CAAE 国际癫痫论坛,2013 -09 - 12[2016 -04 - 10]. http://kreader. cnki. net/Kreader/CatalogViewPage. aspx? dbCode =IPFD&filename = KDXX201309CX)1287 &tablename = IPFD2013&compose = &first = l&uid =.

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部